Hana Biosciences Appoints Craig W. Carlson as Chief Financial Officer
March 11, 2010 08:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 11, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences to Present at the 12th Annual BIO CEO & Investor Conference
February 01, 2010 07:30 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 1, 2010 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Appoints Howard Furst, M.D., M.B.A., to Board of Directors
December 16, 2009 07:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced the...
Hana Biosciences Announces Positive Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia at 51st American Society of Hematology Annual Meeting
December 07, 2009 11:01 ET
|
Talon Therapeutics, Inc.
--36% Overall Response Rate and 21% Complete Remission Rate--
--Median Overall Survival of 7.3 Months in Complete Responders--
SOUTH SAN FRANCISCO, Calif., Dec. 7, 2009 (GLOBE NEWSWIRE)...
Hana Biosciences Completes Enrollment in Pivotal Phase 2 rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia
December 02, 2009 07:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 2, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it...
Hana Biosciences to Present Data From Pivotal rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblastic Leukemia
December 01, 2009 07:00 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Dec. 1, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences to Present at the 21st Annual Piper Jaffray Healthcare Conference
November 24, 2009 16:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Announces Third Quarter 2009 Results
November 13, 2009 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB) announced today financial results for the three and nine months ended September 30, 2009.
"Highlights of...
Hana Biosciences to Present at the 8th Annual BIO Investor Forum
October 22, 2009 07:05 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that...
Hana Biosciences Completes $12.4 Million Private Placement
October 08, 2009 19:33 ET
|
Talon Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences (OTCBB:HNAB) announced today that it has completed its previously disclosed private placement of units of its securities...